ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq
The company said it financed the buyout with cash on hand, and that no additional royalty is due to SWK on net revenue beginning
Shares of the company were down more than 1% in recent Tuesday premarket activity.
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
© 1999-2025 Midnight Trader, Inc. All rights reserved.

Related News
-
Giga Metals to Raise $500,000 in Non-Brokered Private Placement
MT Newswires - 25 minutes ago
-
Castellum Closes $4.5 Million Unit Offering
MT Newswires - 26 minutes ago
-
Trump hosts top US oil chief executives as trade wars loom
Reuters - 28 minutes ago
-
Brookfield leads race to buy Colonial Pipeline, Bloomberg News reports
Reuters - 40 minutes ago
-
Pegasystems Achieves FedRAMP High Authority to Operate Status
MT Newswires - 40 minutes ago
-
What's Going On With Apollo Global Stock On Wednesday?
Benzinga - 41 minutes ago
-
Market Chatter: Nvidia Acquires Data Startup Gretel
MT Newswires - 41 minutes ago